Swot Analysis of "Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B)" written by Robert D. Landel, Rebecca Goldberg includes – strengths weakness that are internal strategic factors of the organization, and opportunities and threats that Uv5972 Wyeth facing as an external strategic factors. Some of the topics covered in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) case study are - Strategic Management Strategies, Operations management, Technology and Leadership & Managing People.
Some of the macro environment factors that can be used to understand the Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) casestudy better are - – challanges to central banks by blockchain based private currencies, increasing government debt because of Covid-19 spendings, increasing commodity prices, increasing inequality as vast percentage of new income is going to the top 1%, competitive advantages are harder to sustain because of technology dispersion, geopolitical disruptions, cloud computing is disrupting traditional business models,
increasing transportation and logistics costs, there is backlash against globalization, etc
Introduction to SWOT Analysis of Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B)
SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University , we believe that protagonist in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) case study can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the Uv5972 Wyeth, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which Uv5972 Wyeth operates in.
According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.
SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix
SWOT analysis of Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) can be done for the following purposes –
1. Strategic planning using facts provided in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) case study
2. Improving business portfolio management of Uv5972 Wyeth
3. Assessing feasibility of the new initiative in Leadership & Managing People field.
4. Making a Leadership & Managing People topic specific business decision
5. Set goals for the organization
6. Organizational restructuring of Uv5972 Wyeth
Strengths Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The strengths of Uv5972 Wyeth in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) Harvard Business Review case study are -
Successful track record of launching new products
– Uv5972 Wyeth has launched numerous new products in last few years, keeping in mind evolving customer preferences and competitive pressures. Uv5972 Wyeth has effective processes in place that helps in exploring new product needs, doing quick pilot testing, and then launching the products quickly using its extensive distribution network.
Ability to lead change in Leadership & Managing People field
– Uv5972 Wyeth is one of the leading players in its industry. Over the years it has not only transformed the business landscape in its segment but also across the whole industry. The ability to lead change has enabled Uv5972 Wyeth in – penetrating new markets, reaching out to new customers, and providing different value propositions to different customers in the international markets.
Effective Research and Development (R&D)
– Uv5972 Wyeth has innovation driven culture where significant part of the revenues are spent on the research and development activities. This has resulted in, as mentioned in case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) - staying ahead in the industry in terms of – new product launches, superior customer experience, highly competitive pricing strategies, and great returns to the shareholders.
Diverse revenue streams
– Uv5972 Wyeth is present in almost all the verticals within the industry. This has provided firm in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) case study a diverse revenue stream that has helped it to survive disruptions such as global pandemic in Covid-19, financial disruption of 2008, and supply chain disruption of 2021.
Highly skilled collaborators
– Uv5972 Wyeth has highly efficient outsourcing and offshoring strategy. It has resulted in greater operational flexibility and bringing down the costs in highly price sensitive segment. Secondly the value chain collaborators of the firm in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) HBR case study have helped the firm to develop new products and bring them quickly to the marketplace.
Training and development
– Uv5972 Wyeth has one of the best training and development program in the industry. The effectiveness of the training programs can be measured in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) Harvard Business Review case study by analyzing – employees retention, in-house promotion, loyalty, new venture initiation, lack of conflict, and high level of both employees and customer engagement.
Cross disciplinary teams
– Horizontal connected teams at the Uv5972 Wyeth are driving operational speed, building greater agility, and keeping the organization nimble to compete with new competitors. It helps are organization to ideate new ideas, and execute them swiftly in the marketplace.
Learning organization
- Uv5972 Wyeth is a learning organization. It has inculcated three key characters of learning organization in its processes and operations – exploration, creativity, and expansiveness. The work place at Uv5972 Wyeth is open place that encourages instructiveness, ideation, open minded discussions, and creativity. Employees and leaders in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) Harvard Business Review case study emphasize – knowledge, initiative, and innovation.
Organizational Resilience of Uv5972 Wyeth
– The covid-19 pandemic has put organizational resilience at the centre of everthing that Uv5972 Wyeth does. Organizational resilience comprises - Financial Resilience, Operational Resilience, Technological Resilience, Organizational Resilience, Business Model Resilience, and Reputation Resilience.
Analytics focus
– Uv5972 Wyeth is putting a lot of focus on utilizing the power of analytics in business decision making. This has put it among the leading players in the industry. The technology infrastructure suggested by Robert D. Landel, Rebecca Goldberg can also help it to harness the power of analytics for – marketing optimization, demand forecasting, customer relationship management, inventory management, information sharing across the value chain etc.
Operational resilience
– The operational resilience strategy in the Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) Harvard Business Review case study comprises – understanding the underlying the factors in the industry, building diversified operations across different geographies so that disruption in one part of the world doesn’t impact the overall performance of the firm, and integrating the various business operations and processes through its digital transformation drive.
High switching costs
– The high switching costs that Uv5972 Wyeth has built up over years in its products and services combo offer has resulted in high retention of customers, lower marketing costs, and greater ability of the firm to focus on its customers.
Weaknesses Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The weaknesses of Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) are -
Lack of clear differentiation of Uv5972 Wyeth products
– To increase the profitability and margins on the products, Uv5972 Wyeth needs to provide more differentiated products than what it is currently offering in the marketplace.
Slow decision making process
– As mentioned earlier in the report, Uv5972 Wyeth has a very deliberative decision making approach. This approach has resulted in prudent decisions, but it has also resulted in missing opportunities in the industry over the last five years. Uv5972 Wyeth even though has strong showing on digital transformation primary two stages, it has struggled to capitalize the power of digital transformation in marketing efforts and new venture efforts.
High dependence on star products
– The top 2 products and services of the firm as mentioned in the Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) HBR case study still accounts for major business revenue. This dependence on star products in has resulted into insufficient focus on developing new products, even though Uv5972 Wyeth has relatively successful track record of launching new products.
Slow to strategic competitive environment developments
– As Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) HBR case study mentions - Uv5972 Wyeth takes time to assess the upcoming competitions. This has led to missing out on atleast 2-3 big opportunities in the industry in last five years.
Products dominated business model
– Even though Uv5972 Wyeth has some of the most successful products in the industry, this business model has made each new product launch extremely critical for continuous financial growth of the organization. firm in the HBR case study - Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) should strive to include more intangible value offerings along with its core products and services.
Interest costs
– Compare to the competition, Uv5972 Wyeth has borrowed money from the capital market at higher rates. It needs to restructure the interest payment and costs so that it can compete better and improve profitability.
Slow to harness new channels of communication
– Even though competitors are using new communication channels such as Instagram, Tiktok, and Snap, Uv5972 Wyeth is slow explore the new channels of communication. These new channels of communication mentioned in marketing section of case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) can help to provide better information regarding products and services. It can also build an online community to further reach out to potential customers.
High dependence on existing supply chain
– The disruption in the global supply chains because of the Covid-19 pandemic and blockage of the Suez Canal illustrated the fragile nature of Uv5972 Wyeth supply chain. Even after few cautionary changes mentioned in the HBR case study - Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B), it is still heavily dependent upon the existing supply chain. The existing supply chain though brings in cost efficiencies but it has left Uv5972 Wyeth vulnerable to further global disruptions in South East Asia.
Low market penetration in new markets
– Outside its home market of Uv5972 Wyeth, firm in the HBR case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) needs to spend more promotional, marketing, and advertising efforts to penetrate international markets.
No frontier risks strategy
– After analyzing the HBR case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B), it seems that company is thinking about the frontier risks that can impact Leadership & Managing People strategy. But it has very little resources allocation to manage the risks emerging from events such as natural disasters, climate change, melting of permafrost, tacking the rise of artificial intelligence, opportunities and threats emerging from commercialization of space etc.
Skills based hiring
– The stress on hiring functional specialists at Uv5972 Wyeth has created an environment where the organization is dominated by functional specialists rather than management generalist. This has resulted into product oriented approach rather than marketing oriented approach or consumers oriented approach.
Opportunities Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The opportunities highlighted in the Harvard Business Review case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) are -
Low interest rates
– Even though inflation is raising its head in most developed economies, Uv5972 Wyeth can still utilize the low interest rates to borrow money for capital investment. Secondly it can also use the increase of government spending in infrastructure projects to get new business.
Manufacturing automation
– Uv5972 Wyeth can use the latest technology developments to improve its manufacturing and designing process in Leadership & Managing People segment. It can use CAD and 3D printing to build a quick prototype and pilot testing products. It can leverage automation using machine learning and artificial intelligence to do faster production at lowers costs, and it can leverage the growth in satellite and tracking technologies to improve inventory management, transportation, and shipping.
Finding new ways to collaborate
– Covid-19 has not only transformed business models of companies in Leadership & Managing People industry, but it has also influenced the consumer preferences. Uv5972 Wyeth can tie-up with other value chain partners to explore new opportunities regarding meeting customer demands and building a rewarding and engaging relationship.
Using analytics as competitive advantage
– Uv5972 Wyeth has spent a significant amount of money and effort to integrate analytics and machine learning into its operations in the sector. This continuous investment in analytics has enabled, as illustrated in the Harvard case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) - to build a competitive advantage using analytics. The analytics driven competitive advantage can help Uv5972 Wyeth to build faster Go To Market strategies, better consumer insights, developing relevant product features, and building a highly efficient supply chain.
Learning at scale
– Online learning technologies has now opened space for Uv5972 Wyeth to conduct training and development for its employees across the world. This will result in not only reducing the cost of training but also help employees in different part of the world to integrate with the headquarter work culture, ethos, and standards.
Buying journey improvements
– Uv5972 Wyeth can improve the customer journey of consumers in the industry by using analytics and artificial intelligence. Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) suggest that firm can provide automated chats to help consumers solve their own problems, provide online suggestions to get maximum out of the products and services, and help consumers to build a community where they can interact with each other to develop new features and uses.
Leveraging digital technologies
– Uv5972 Wyeth can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.
Remote work and new talent hiring opportunities
– The widespread usage of remote working technologies during Covid-19 has opened opportunities for Uv5972 Wyeth to expand its talent hiring zone. According to McKinsey Global Institute, 20% of the high end workforce in fields such as finance, information technology, can continously work from remote local post Covid-19. This presents a really great opportunity for Uv5972 Wyeth to hire the very best people irrespective of their geographical location.
Loyalty marketing
– Uv5972 Wyeth has focused on building a highly responsive customer relationship management platform. This platform is built on in-house data and driven by analytics and artificial intelligence. The customer analytics can help the organization to fine tune its loyalty marketing efforts, increase the wallet share of the organization, reduce wastage on mainstream advertising spending, build better pricing strategies using personalization, etc.
Developing new processes and practices
– Uv5972 Wyeth can develop new processes and procedures in Leadership & Managing People industry using technology such as automation using artificial intelligence, real time transportation and products tracking, 3D modeling for concept development and new products pilot testing etc.
Reconfiguring business model
– The expansion of digital payment system, the bringing down of international transactions costs using Bitcoin and other blockchain based currencies, etc can help Uv5972 Wyeth to reconfigure its entire business model. For example it can used blockchain based technologies to reduce piracy of its products in the big markets such as China. Secondly it can use the popularity of e-commerce in various developing markets to build a Direct to Customer business model rather than the current Channel Heavy distribution network.
Use of Bitcoin and other crypto currencies for transactions
– The popularity of Bitcoin and other crypto currencies as asset class and medium of transaction has opened new opportunities for Uv5972 Wyeth in the consumer business. Now Uv5972 Wyeth can target international markets with far fewer capital restrictions requirements than the existing system.
Identify volunteer opportunities
– Covid-19 has impacted working population in two ways – it has led to people soul searching about their professional choices, resulting in mass resignation. Secondly it has encouraged people to do things that they are passionate about. This has opened opportunities for businesses to build volunteer oriented socially driven projects. Uv5972 Wyeth can explore opportunities that can attract volunteers and are consistent with its mission and vision.
Threats Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The threats mentioned in the HBR case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) are -
Capital market disruption
– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of Uv5972 Wyeth.
Instability in the European markets
– European Union markets are facing three big challenges post Covid – expanded balance sheets, Brexit related business disruption, and aggressive Russia looking to distract the existing security mechanism. Uv5972 Wyeth will face different problems in different parts of Europe. For example it will face inflationary pressures in UK, France, and Germany, balance sheet expansion and demand challenges in Southern European countries, and geopolitical instability in the Eastern Europe.
Aging population
– As the populations of most advanced economies are aging, it will lead to high social security costs, higher savings among population, and lower demand for goods and services in the economy. The household savings in US, France, UK, Germany, and Japan are growing faster than predicted because of uncertainty caused by pandemic.
Backlash against dominant players
– US Congress and other legislative arms of the government are getting tough on big business especially technology companies. The digital arm of Uv5972 Wyeth business can come under increasing regulations regarding data privacy, data security, etc.
Environmental challenges
– Uv5972 Wyeth needs to have a robust strategy against the disruptions arising from climate change and energy requirements. EU has identified it as key priority area and spending 30% of its 880 billion Euros European post Covid-19 recovery funds on green technology. Uv5972 Wyeth can take advantage of this fund but it will also bring new competitors in the Leadership & Managing People industry.
Barriers of entry lowering
– As technology is more democratized, the barriers to entry in the industry are lowering. It can presents Uv5972 Wyeth with greater competitive threats in the near to medium future. Secondly it will also put downward pressure on pricing throughout the sector.
Easy access to finance
– Easy access to finance in Leadership & Managing People field will also reduce the barriers to entry in the industry, thus putting downward pressure on the prices because of increasing competition. Uv5972 Wyeth can utilize it by borrowing at lower rates and invest it into research and development, capital expenditure to fortify its core competitive advantage.
High dependence on third party suppliers
– Uv5972 Wyeth high dependence on third party suppliers can disrupt its processes and delivery mechanism. For example -the current troubles of car makers because of chip shortage is because the chip companies started producing chips for electronic companies rather than car manufacturers.
High level of anxiety and lack of motivation
– the Great Resignation in United States is the sign of broader dissatisfaction among the workforce in United States. Uv5972 Wyeth needs to understand the core reasons impacting the Leadership & Managing People industry. This will help it in building a better workplace.
Technology disruption because of hacks, piracy etc
– The colonial pipeline illustrated, how vulnerable modern organization are to international hackers, miscreants, and disruptors. The cyber security interruption, data leaks, etc can seriously jeopardize the future growth of the organization.
Regulatory challenges
– Uv5972 Wyeth needs to prepare for regulatory challenges as consumer protection groups and other pressure groups are vigorously advocating for more regulations on big business - to reduce inequality, to create a level playing field, to product data privacy and consumer privacy, to reduce the influence of big money on democratic institutions, etc. This can lead to significant changes in the Leadership & Managing People industry regulations.
New competition
– After the dotcom bust of 2001, financial crisis of 2008-09, the business formation in US economy had declined. But in 2020 alone, there are more than 1.5 million new business applications in United States. This can lead to greater competition for Uv5972 Wyeth in the Leadership & Managing People sector and impact the bottomline of the organization.
Consumer confidence and its impact on Uv5972 Wyeth demand
– There is a high probability of declining consumer confidence, given – high inflammation rate, rise of gig economy, lower job stability, increasing cost of living, higher interest rates, and aging demography. All the factors contribute to people saving higher rate of their income, resulting in lower consumer demand in the industry and other sectors.
Weighted SWOT Analysis of Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) Template, Example
Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers in the HBR case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants.
We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –
First stage for doing weighted SWOT analysis of the case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.
Second stage for conducting weighted SWOT analysis of the Harvard case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.
Third stage of constructing weighted SWOT analysis of Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) is to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that Uv5972 Wyeth needs to make to build a sustainable competitive advantage.